Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Structural Heart Occlusion Devices are used to close defects in heart, reducing the risk of stroke and treating congenital heart defects. GlobalData uses proprietary data and analytics to provide a comprehensive report on the structural heart occlusion devices devices market, including market shares of different players within Portugal. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the structural heart occlusion devices market in Portugal was Abbott Laboratories followed by Boston Scientific, W. L. Gore & Associates, AtriCure, Occlutech, pfm medical and LifeTech Scientific.
Structural Heart Occlusion Devices provide minimally invasive treatment options for the closure of congenital heart defects and for stroke risk reduction. The closure interventions are typically performed through a transcatheter approach, which eliminates the need for open heart surgery, enabling faster recovery times. The structural heart occlusion device consists of Atrial Septal Defect Occluders, Ventricular Septal Defect Occluders, Patent Ductus Arteriosus Closure Devices, Patent Foramen Ovale Closure Devices and Left Atrial Appendage Closure Devices.
The value of the structural heart occlusion devices devices market within Portugal was expected to be over $5m in 2023.
For the latest complete market share analysis of structural heart occlusion devices device market in Portugal, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
